In breast cancer cells, knockdown of ESRP1 (Epithelial Splicing Regulatory Protein 1) decreased the expression of fatty acid, lipid metabolism targets and oxidoreductases including PHGDH (D-3-phosphoglycerate dehydrogenase). This evidence concerns the gene PHGDH and breast carcinoma.